CS, K., & SS, H. (2021). Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: A meta-analysis. Journal of thrombosis and thrombolysis, 52(1), 124. https://doi.org/10.1007/s11239-021-02436-0
Chicago Style (17th ed.) CitationCS, Kow, and Hasan SS. "Use of Antiplatelet Drugs and the Risk of Mortality in Patients with COVID-19: A Meta-analysis." Journal of Thrombosis and Thrombolysis 52, no. 1 (2021): 124. https://doi.org/10.1007/s11239-021-02436-0.
MLA (9th ed.) CitationCS, Kow, and Hasan SS. "Use of Antiplatelet Drugs and the Risk of Mortality in Patients with COVID-19: A Meta-analysis." Journal of Thrombosis and Thrombolysis, vol. 52, no. 1, 2021, p. 124, https://doi.org/10.1007/s11239-021-02436-0.
Warning: These citations may not always be 100% accurate.